======= VEZF1 ======= == Gene Information == * **Official Symbol**: VEZF1 * **Official Name**: vascular endothelial zinc finger 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=7716|7716]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q14119|Q14119]] * **Interactions**: [[https://thebiogrid.org/search.php?search=VEZF1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20VEZF1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606747|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Possible transcription factor. Specifically binds to the CT/GC-rich region of the interleukin-3 promoter and mediates tax transactivation of IL-3. {ECO:0000269|PubMed:8035792}. No Pfam Domain information is available for this gene. |positive regulation of endothelial cell differentiation| |regulation of endothelial cell differentiation| |endothelial cell development| |cellular defense response| |positive regulation of epithelial cell differentiation| |endothelial cell differentiation| |endothelium development| |regulation of epithelial cell differentiation| |epithelial cell development| |RNA polymerase II regulatory region sequence-specific DNA binding| |angiogenesis| |blood vessel morphogenesis| |DNA-binding transcription activator activity, RNA polymerase II-specific| |transcription by RNA polymerase II| |blood vessel development| |vasculature development| |cardiovascular system development| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |tube morphogenesis| |epithelial cell differentiation| |tube development| |circulatory system development| |anatomical structure formation involved in morphogenesis| |positive regulation of cell differentiation| |nucleobase-containing compound biosynthetic process| |epithelium development| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |positive regulation of transcription by RNA polymerase II| |organic cyclic compound biosynthetic process| |defense response| |positive regulation of developmental process| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |cell development| |RNA metabolic process| |cellular macromolecule biosynthetic process| |positive regulation of RNA metabolic process| |tissue development| |macromolecule biosynthetic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|-2.45| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2.33| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|-2.28| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|-2.11| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|-1.82| |[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|-1.81| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|-1.79| |[[:results:exp264|Arsenate 40μM R06 exp264]]|1.77| |[[:results:exp432|YM155 0.001μM R08 exp432]]|1.77| |[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|1.84| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|1.9| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|2.11| |[[:results:exp510|Nicotine 3000μM R08 exp510]]|2.19| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|2.5| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|2.62| ^Gene^Correlation^ |[[:human genes:t:tgif1|TGIF1]]|0.506| |[[:human genes:s:syk|SYK]]|0.497| |[[:human genes:r:rhoh|RHOH]]|0.495| |[[:human genes:m:mapkap1|MAPKAP1]]|0.472| |[[:human genes:p:pik3cd|PIK3CD]]|0.463| |[[:human genes:r:rbm7|RBM7]]|0.459| |[[:human genes:r:rictor|RICTOR]]|0.456| |[[:human genes:c:cd79a|CD79A]]|0.453| |[[:human genes:c:cd19|CD19]]|0.436| |[[:human genes:p:pdcl|PDCL]]|0.43| |[[:human genes:i:igll1|IGLL1]]|0.427| |[[:human genes:c:crebbp|CREBBP]]|0.407| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3587 * **Expression level (log2 read counts)**: 6.15 {{:chemogenomics:nalm6 dist.png?nolink |}}